BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9551772)

  • 1. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.
    Li XM; Perry KW; Wong DT; Bymaster FP
    Psychopharmacology (Berl); 1998 Mar; 136(2):153-61. PubMed ID: 9551772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
    Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
    Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.
    Volonté M; Monferini E; Cerutti M; Fodritto F; Borsini F
    J Neurochem; 1997 Jul; 69(1):182-90. PubMed ID: 9202309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
    Rollema H; Lu Y; Schmidt AW; Sprouse JS; Zorn SH
    Biol Psychiatry; 2000 Aug; 48(3):229-37. PubMed ID: 10924666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex.
    Zhang W; Perry KW; Wong DT; Potts BD; Bao J; Tollefson GD; Bymaster FP
    Neuropsychopharmacology; 2000 Sep; 23(3):250-62. PubMed ID: 10942849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Kuroki T; Dai J; Meltzer HY
    Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic clozapine selectively decreases prefrontal cortex dopamine as shown by simultaneous cortical, accumbens, and striatal microdialysis in freely moving rats.
    Hernandez L; Hoebel BG
    Pharmacol Biochem Behav; 1995 Nov; 52(3):581-9. PubMed ID: 8545478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions.
    Radke JM; Owens MJ; Ritchie JC; Nemeroff CB
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11462-4. PubMed ID: 9736759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.
    Nomikos GG; Iurlo M; Andersson JL; Kimura K; Svensson TH
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):147-56. PubMed ID: 7862887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation.
    Heidbreder CA; Foxton R; Cilia J; Hughes ZA; Shah AJ; Atkins A; Hunter AJ; Hagan JJ; Jones DN
    Psychopharmacology (Berl); 2001 Jul; 156(2-3):338-51. PubMed ID: 11549234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
    Ichikawa J; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain.
    Westerink BH; de Boer P; de Vries JB; Kruse CG; Long SK
    Eur J Pharmacol; 1998 Nov; 361(1):27-33. PubMed ID: 9851538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
    Karoum F; Chrapusta SJ; Egan MF
    J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study.
    Jaskiw GE; Collins KA; Pehek EA; Yamamoto BK
    Neuropsychopharmacology; 2001 Jul; 25(1):149-56. PubMed ID: 11377928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.
    Li SX; Perry KW; Wong DT
    Neuropharmacology; 2002 Feb; 42(2):181-90. PubMed ID: 11804614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
    Masana M; Bortolozzi A; Artigas F
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):53-68. PubMed ID: 20701825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T; Meltzer HY; Ichikawa J
    J Pharmacol Exp Ther; 1999 Feb; 288(2):774-81. PubMed ID: 9918588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo.
    Rowley HL; Needham PL; Kilpatrick IC; Heal DJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):187-92. PubMed ID: 10685875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
    Bymaster FP; Katner JS; Nelson DL; Hemrick-Luecke SK; Threlkeld PG; Heiligenstein JH; Morin SM; Gehlert DR; Perry KW
    Neuropsychopharmacology; 2002 Nov; 27(5):699-711. PubMed ID: 12431845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.